PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Heger, L.* ; Hofer, T.P. ; Bigley, V.* ; de Vries, I.J.M.* ; Dalod, M.* ; Dudziak, D.* ; Ziegler-Heitbrock, L.*

Subsets of CD1c+DCs: Dendritic cell versus monocyte lineage.

Front. Immunol. 11:559166 (2020)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14(+)and a CD14(-)subset can be detected. The CD14(+)subset shares features with monocytes, and this includes substantially higher expression levels for CD64, CD115, CD163, and S100A8/9. We review the current knowledge of these CD1c(+)CD14(+)cells as compared to the CD1c(+)CD14(-)cells with respect to phenotype, function, transcriptomics, and ontogeny. Here, we discuss informative mutations, which suggest that two populations have different developmental requirements. In addition, we cover subsets of CD11c(+)CD8(-)DC2s in the mouse, where CLEC12A(+)ESAM(low)cells, as compared to the CLEC12A(-)ESAM(high)subset, also express higher levels of monocyte-associated markers CD14, CD3, and CD115. Finally, we summarize, for both man and mouse, the data on lower antigen presentation and higher cytokine production in the monocyte-marker expressing DC2 subset, which demonstrate that the DC2 subsets are also functionally distinct.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.085
1.224
9
10
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Dc2 ; Cd1c ; Cd172 ; Cd301 ; Cd14 ; Dendritic Cells ; Dc Subsets; Antigen Cross-presentation; Signal-regulatory Protein; Mononuclear Phagocytes; Molecular-cloning; Human Blood; In-vitro; Expression; Macrophage; Receptor; Lectin
Language english
Publication Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 1664-3224
e-ISSN 1664-3224
Journal Frontiers in Immunology
Quellenangaben Volume: 11, Issue: , Pages: , Article Number: 559166 Supplement: ,
Publisher Frontiers
Publishing Place Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Reviewing status Peer reviewed
Institute(s) Institute of Virology (VIRO)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502710-001
Grants Wellcome Trust
Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)
Interdisziplinares Zentrum fur Klinische Forschung
Agency national research (ANR)/German Research Foundation programBayresq.Net (Bavarian Ministry of Sciences)
German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)]
DOI 10.3389/fimmu.2020.559166
WOS ID WOS:000579227200001
Scopus ID 85092749275
PubMed ID 33101275
Erfassungsdatum 2020-10-30
[➜Report correction]